220 related articles for article (PubMed ID: 20156773)
1. Prognostic significance of the hair follicle stem cell marker nestin in patients with malignant melanoma.
Tanabe K; Amoh Y; Kanoh M; Takasu H; Sakai N; Sato Y; Katsuoka K
Eur J Dermatol; 2010; 20(3):283-8. PubMed ID: 20156773
[TBL] [Abstract][Full Text] [Related]
2. Nestin is expressed in HMB-45 negative melanoma cells in dermal parts of nodular melanoma.
Kanoh M; Amoh Y; Tanabe K; Maejima H; Takasu H; Katsuoka K
J Dermatol; 2010 Jun; 37(6):505-11. PubMed ID: 20536663
[TBL] [Abstract][Full Text] [Related]
3. Expression of the hair stem cell-specific marker nestin in epidermal and follicular tumors.
Kanoh M; Amoh Y; Sato Y; Katsuoka K
Eur J Dermatol; 2008; 18(5):518-23. PubMed ID: 18693153
[TBL] [Abstract][Full Text] [Related]
4. Expression of embryonic stem cell markers SOX2 and nestin in dermatofibrosarcoma protuberans and dermatofibroma.
Sellheyer K; Nelson P; Patel RM
J Cutan Pathol; 2011 May; 38(5):415-9. PubMed ID: 21251041
[TBL] [Abstract][Full Text] [Related]
5. Nestin expression in cutaneous melanomas and melanocytic nevi.
Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
[TBL] [Abstract][Full Text] [Related]
6. Nestin expression as a new marker in malignant peripheral nerve sheath tumors.
Shimada S; Tsuzuki T; Kuroda M; Nagasaka T; Hara K; Takahashi E; Hayakawa S; Ono K; Maeda N; Mori N; Illei PB
Pathol Int; 2007 Feb; 57(2):60-7. PubMed ID: 17300669
[TBL] [Abstract][Full Text] [Related]
7. Nestin and SOX9 and SOX10 transcription factors are coexpressed in melanoma.
Bakos RM; Maier T; Besch R; Mestel DS; Ruzicka T; Sturm RA; Berking C
Exp Dermatol; 2010 Aug; 19(8):e89-94. PubMed ID: 19845757
[TBL] [Abstract][Full Text] [Related]
8. Micropthalmia transcription factor: a new prognostic marker in intermediate-thickness cutaneous malignant melanoma.
Salti GI; Manougian T; Farolan M; Shilkaitis A; Majumdar D; Das Gupta TK
Cancer Res; 2000 Sep; 60(18):5012-6. PubMed ID: 11016620
[TBL] [Abstract][Full Text] [Related]
9. Nestin as a diagnostic and prognostic marker: immunohistochemical analysis of its expression in different tumours.
Ehrmann J; Kolár Z; Mokry J
J Clin Pathol; 2005 Feb; 58(2):222-3. PubMed ID: 15677549
[TBL] [Abstract][Full Text] [Related]
10. Spatiotemporal expression pattern of neuroepithelial stem cell marker nestin suggests a role in dermal homeostasis, neovasculogenesis, and tumor stroma development: a study on embryonic and adult human skin.
Sellheyer K; Krahl D
J Am Acad Dermatol; 2010 Jul; 63(1):93-113. PubMed ID: 19864043
[TBL] [Abstract][Full Text] [Related]
11. The stem cell marker nestin predicts poor prognosis in human melanoma.
Piras F; Perra MT; Murtas D; Minerba L; Floris C; Maxia C; Demurtas P; Ugalde J; Ribatti D; Sirigu P
Oncol Rep; 2010 Jan; 23(1):17-24. PubMed ID: 19956860
[TBL] [Abstract][Full Text] [Related]
12. Nestin and vimentin colocalization affects the subcellular location of glucocorticoid receptor in cutaneous melanoma.
Lai S; Piras F; Spiga S; Perra MT; Minerba L; Piga M; Mura E; Murtas D; Demurtas P; Corrias M; Maxia C; Ferreli C; Sirigu P
Histopathology; 2013 Feb; 62(3):487-98. PubMed ID: 23072594
[TBL] [Abstract][Full Text] [Related]
13. [Nevus associated malignant melanomas--diagnostic validation and prognosis].
Stadler R; Garbe C
Hautarzt; 1991 Jul; 42(7):424-9. PubMed ID: 1938395
[TBL] [Abstract][Full Text] [Related]
14. Nestin is highly expressed in advanced-stage melanomas and neurotized nevi.
Akiyama M; Matsuda Y; Ishiwata T; Naito Z; Kawana S
Oncol Rep; 2013 Apr; 29(4):1595-9. PubMed ID: 23417116
[TBL] [Abstract][Full Text] [Related]
15. Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications.
Mangiola A; Lama G; Giannitelli C; De Bonis P; Anile C; Lauriola L; La Torre G; Sabatino G; Maira G; Jhanwar-Uniyal M; Sica G
Clin Cancer Res; 2007 Dec; 13(23):6970-7. PubMed ID: 18056172
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein D expression in cutaneous malignant melanoma.
Miranda E; Vizoso F; Martín A; Quintela I; Corte MD; Seguí ME; Ordiz I; Merino AM
J Surg Oncol; 2003 Jun; 83(2):99-105. PubMed ID: 12772203
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
18. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
Shanesmith RP; Smart C; Cassarino DS
Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
[TBL] [Abstract][Full Text] [Related]
19. Hair follicle stem cell marker nestin expression in regenerating hair follicles of patients with alopecia areata.
Amoh Y; Maejima H; Niiyama S; Mii S; Hamada Y; Saito N; Katsuoka K
Eur J Dermatol; 2011; 21(2):209-12. PubMed ID: 21524985
[TBL] [Abstract][Full Text] [Related]
20. Nestin expression in different tumours and its relevance to malignant grade.
Yang XH; Wu QL; Yu XB; Xu CX; Ma BF; Zhang XM; Li SN; Lahn BT; Xiang AP
J Clin Pathol; 2008 Apr; 61(4):467-73. PubMed ID: 17873113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]